Brazil says the U.S. will send more than 2 million tablets of the antimalarial drug hydroxychloroquine to Brazil. Previously, hydroxychloroquine was called an anti-epidemic drug by the U.S. president, but on the 25th of this month WHO called off a new coronary treatment trial for safety reasons. Brazilian President Jair Bolsonaro told supporters and media outside the presidential palace that U.S. President Donald Trump will send more than 2 million antimalarial tablets to Brazil, ABC News reported. Details of the deal are still being negotiated.
Bossonaro, who has reportedly come under fire for his handling of Brazil’s new coronal outbreak, has been promoting hydroxychloroquine as a treatment for new coronary pneumonia, although there is no evidence that the drug can prevent the disease. Bosonaro has said he has left a box of antimalarial drugs chloroquine for his 93-year-old mother in case he needs it, following information about his medication in the United States.
Meanwhile, U.S. President Donald Trump is also a fan of the drug “Treating New Coronary Pneumonia,” which even announced earlier this month that he was taking the drug daily to prevent infection after two White House staffers tested positive for a new crown. This has accelerated the spread and use of hydroxychloroquine in the United States.
However, new research has found that hydroxychloroquine is not therapeutic, but rather causes more serious damage to the fragile body of new corona patients. A study published Friday in the Lancet medical journal showed that patients treated with chloroquine or its analogue hydroxychloroquine had a higher risk of death in more than 96,000 cases of neo-coronary pneumonia in hospitals around the world than those who did not receive antimalarial drugs. WHO announced on the 25th, for safety reasons, the suspension of hydroxychloroquine treatment of new crown testing.
Earlier this week, Mr. Trump suspended travel from Brazil to the United States as Brazil became a new hot spot for the new pandemic. But the new rules do not affect economic and trade ties between Brazil and the United States.
Brazil is now the worst country in Latin America, with the second-highest number of confirmed cases after the United States. As of 8:32 p.m. Beijing time on the 28th, real-time data from Johns Hopkins University in the United States showed that the cumulative number of confirmed cases of new coronary pneumonia in Brazil reached 411,821, with a cumulative death toll of 25,598. Brazil will see its peak in June, with more than 3,000 new deaths in a single day and more than 220,000 deaths by August, according to a team at the University of Washington.